An Analysis of Trafficking Receptors Shows that CD44 and P-Selectin Glycoprotein Ligand-1 Collectively Control the Migration of Activated Human T-Cells
KAUST Grant NumberCRG2_R2_13_MERZ_KAUST_1
Permanent link to this recordhttp://hdl.handle.net/10754/623673
MetadataShow full item record
AbstractSelectins guide the traffic of activated T-cells through the blood stream by mediating their tethering and rolling onto inflamed endothelium, in this way acting as beacons to help navigate them to sites of inflammation. Here, we present a comprehensive analysis of E-selectin ligands expressed on activated human T-cells. We identified several novel glycoproteins that function as E-selectin ligands. Specifically, we compared the role of P-selectin glycoprotein ligand-1 (PSGL-1) and CD43, known E-selectin ligands, to CD44, a ligand that has not previously been characterized as an E-selectin ligand on activated human T-cells. We showed that CD44 acts as a functional E-selectin ligand when expressed on both CD4+ and CD8+ T-cells. Moreover, the CD44 protein carries a binding epitope identifying it as hematopoietic cell E- and/or L-selectin ligand (HCELL). Furthermore, by knocking down these ligands individually or together in primary activated human T-cells, we demonstrated that CD44/HCELL, and not CD43, cooperates with PSGL-1 as a major E-selectin ligand. Additionally, we demonstrated the relevance of our findings to chronic autoimmune disease, by showing that CD44/HCELL and PSGL-1, but not CD43, from T-cells isolated from psoriasis patients, bind E-selectin.
CitationAli AJ, Abuelela AF, Merzaban JS (2017) An Analysis of Trafficking Receptors Shows that CD44 and P-Selectin Glycoprotein Ligand-1 Collectively Control the Migration of Activated Human T-Cells. Frontiers in Immunology 8. Available: http://dx.doi.org/10.3389/fimmu.2017.00492.
SponsorsThis work was supported by the King Abdullah University of Science and Technology (KAUST) Faculty Baseline Research Funding Program as well as a Competitive Research Grant (CRG2_R2_13_MERZ_KAUST_1) to JM. The authors would like to thank Dr. Samir M. Hamdan for discussions regarding SPR studies and Ms. Samar A. Rostom for her support in the management of the lab. The authors would also like to thank Carolyn Unck from the Academic Writing Services at KAUST for editing the manuscript. In addition, a special thanks to Dr. Aswini K. Panigrahi from the Bioscience Core Lab facility for the mass spectrometry assistance and the rest of the members of the Cell Migration and Signaling Laboratory for their support.
PublisherFrontiers Media SA
JournalFrontiers in Immunology
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
- CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.
- Authors: Velázquez F, Grodecki-Pena A, Knapp A, Salvador AM, Nevers T, Croce K, Alcaide P
- Issue date: 2016 Feb 1
- differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1.
- Authors: Dimitroff CJ, Lee JY, Schor KS, Sandmaier BM, Sackstein R
- Issue date: 2001 Dec 14
- CD43 collaborates with P-selectin glycoprotein ligand-1 to mediate E-selectin-dependent T cell migration into inflamed skin.
- Authors: Matsumoto M, Shigeta A, Furukawa Y, Tanaka T, Miyasaka M, Hirata T
- Issue date: 2007 Feb 15
- Core 1-derived O-glycans are essential E-selectin ligands on neutrophils.
- Authors: Yago T, Fu J, McDaniel JM, Miner JJ, McEver RP, Xia L
- Issue date: 2010 May 18
- HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.
- Authors: Burdick MM, Chu JT, Godar S, Sackstein R
- Issue date: 2006 May 19